Репозиторий Университета

Correction: Sofosbuvir-based salvage therapy for HCV infection in cirrhotic patients with DAA failure and multidrug resistance (Antivir Ther (2018) DOI: 10.3851/IMP3266)


  • Abdurakhmanov D.
  • Rozina T.
  • Nikulkina E.
  • Nabatchikova E.
  • Chulanov V.
  • Moiseev S.
Дата публикации:01.01.2018
Журнал: Antiviral Therapy
БД: Scopus
Ссылка: Scopus

Аннтотация

©2018 International Medical Press. The publisher would like to report an error that appeared in a recently published article [1]. The word ‘dasabuvir’ should have read ‘daclatasvir’ in the paragraph regarding Patient 3. The correct sentence is as follows: ‘The patient was treated twice with sofosbuvir and daclatasvir for 12 weeks and then with RBV for 24 weeks’. This has been corrected as of 10 October 2018. The authors apologize for this error.


Вернуться назад